The Swiss specialty pharmaceuticals company, Vifor Pharma, is up 15.6 percent at CHF 120 (USD 130,4) following news that Australian CSL wants to take over the Swiss firm, writes Bloomberg News, citing Australian Financial Reviews.
CSL has tasked Bank of America with advising the purchase, including the possibility of raising capital of AUD 4bn (USD 2.8bn) from investors.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
WS Audiology brings in head of EMEA region from Coloplast
The hearing aid manufacturer has appointed Coloplast’s now outgoing president for emerging markets as president for the EMEA region.
Dupixent could dominate pediatric eczema market for up to a decade, analysis finds
Sanofi and Regeneron will be able to call themselves market leaders within atopic eczema treatment for children aged 6 months to 5 for years to come, according to Globaldata.
FDA advisors support approval for Ferring's intestinal infection medicine
All signs indicate that Ferring Pharmaceuticals is on the cusp of being market authorized for its biologic candidate against C. difficile infection.
Pharmacosmos expects massive growth in four years
The company’s new chief executive has ambitions of reaching a DKK 2.5bn (USD 325m) revenue within the time frame.
The Lundbeck Foundation, ATP, LEGO asset manager join forces on secretive project
Three of Denmark’s biggest funds have come together for a yet unknown project, which includes the establishment of three new firms.
Product specialist in Cardio Rhythm Management, Zealand 
Senior Clinical Research Scientist 
Experienced IT Business Solutions Manager for the Danish Medicines Agency 
Nordic Key Account Manager, Hollister & Dansac 
Senior CMC Regulatory Manager 
Scientist Radiochemistry 
Regulatory Affairs CMC Specialist 
Manager of QA, BHS Logistics 
Drug Safety Associate 
Vice President, Medical Affairs 
Pharmacovigilance & Regulatory Assistant with an interest in non-fiction 
Lab Manager 
KLIFO is looking for a Compliance Coordinator for our Glostrup office 
Chief Business Officer